GRIGGIO, VALENTINA
GRIGGIO, VALENTINA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells
2020-01-01 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target
2016-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
2018-01-01 Griggio V, Vitale C, Todaro M, Mauro FR, Salvetti C, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
2019-01-01 Griggio V, Vitale C, Salvetti C, Mauro FR, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M.
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL)
2011-01-01 M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
2010-01-01 Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia
2011-01-01 Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)
2012-01-01 Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib
2020-01-01 Perutelli F, Griggio V, Vitale C, Mauro FR, Salvetti C, Boccellato E, Pietrasanta D, Vincelli ID, Ghia P, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs
2019-01-01 Vitale C, Salvetti C, Griggio V, Scamuffa MC, Zamprogna G, Visentin A, Cassin R, Laurenti L, Murru R, Rivela P, Marchetti M, Gentile M, Pennese E, Reda G, Trentin L, Tedeschi A, Mauro FR, Foà R, Boccadoro M, Coscia M
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET
2016-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET
2018-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, AA; Laurenti, L; Del Poeta, G; Mauro, FR; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE
2017-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells | 2020 | Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M. | |
| HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target | 2016 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia | 2018 | Griggio V, Vitale C, Todaro M, Mauro FR, Salvetti C, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M | |
| Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia | 2019 | Griggio V, Vitale C, Salvetti C, Mauro FR, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M | |
| IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M. | |
| Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) | 2011 | M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia | |
| IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | 2010 | Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia | |
| Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia | 2011 | Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) | 2012 | Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia | |
| IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 2011 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib | 2020 | Perutelli F, Griggio V, Vitale C, Mauro FR, Salvetti C, Boccellato E, Pietrasanta D, Vincelli ID, Ghia P, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M | |
| Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs | 2019 | Vitale C, Salvetti C, Griggio V, Scamuffa MC, Zamprogna G, Visentin A, Cassin R, Laurenti L, Murru R, Rivela P, Marchetti M, Gentile M, Pennese E, Reda G, Trentin L, Tedeschi A, Mauro FR, Foà R, Boccadoro M, Coscia M | |
| REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET | 2016 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M | |
| REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET | 2018 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, AA; Laurenti, L; Del Poeta, G; Mauro, FR; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE | 2017 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M |